Reflecting 25 years of progress and partnership, NephCure strengthens its commitment to ensuring every individual with rare, protein-spilling kidney disease can reach the care and treatments they deserve.
PHILADELPHIA, PA (January 6, 2026) – NephCure, a leading non-profit dedicated to improving the lives of people affected by rare kidney diseases, announces a new mission statement that reflects both the extraordinary progress achieved for rare, protein-spilling kidney diseases (RKD) and the organization’s vision for the next era of patient support. The new mission ensures equitable access to care and emerging treatment for every person living with these debilitating diseases.
For more than a quarter century, NephCure has worked alongside patients, caregivers, researchers, industry, and physicians to transform the RKD landscape. When NephCure was first founded, there was little scientific understanding of RKD, no FDA-approved treatments, and virtually no drugs in development.
Thanks to the hard work of this community, that reality has changed. NephCure has helped make six FDA-approved treatments possible, fueled more than 60 clinical trials, and built a thriving community of over 40,000 families who have found knowledge, hope, and connection.
As scientific breakthroughs accelerate, NephCure recognizes FDA-approved treatments are not the finish line, but rather the starting line. Too many families still face barriers: late diagnosis, difficulty finding expert physicians, and inequities that delay or block access to care and new treatments.
To meet this moment, NephCure introduces its new mission statement:
To ensure that all individuals with rare, protein-spilling kidney disease have equitable access to the care and treatments that offer them the best kidney health outcome possible.
This new mission strengthens NephCure’s longstanding work and reaffirms its commitment to walking beside patients while also adapting to the change needed in order to make these treatments truly accessible for all.
NephCure is uniquely positioned to create change because they work at many levels. The organization brings together researchers, clinicians, industry leaders, and policymakers to set priorities and raise the standard of care. At the same time, we walk beside families— providing navigation, education, advocacy, and community.
This approach ensures that progress in science becomes progress in patients’ lives. It comes to life through four guiding commitments:
- Optimizing outcomes through earlier diagnoses and faster connections to expert care.
- Empowering patients with knowledge, tools, and support to navigate the healthcare system.
- Amplifying patient voices so lived experiences shape research, policy, and care.
Fostering community and equity by cultivating a trusted home for all who are affected by RKD.
About NephCure:
NephCure’s mission is to ensure that all individuals with rare, protein-spilling kidney disease have equitable access to the care and treatments that offer them the best kidney health outcome possible. Founded in 2000 by a group of committed patient parents, NephCure has invested more than $40 million in kidney disease research and helped create a landscape where there are now new treatments and more than 60 interventional drug trials for rare kidney diseases. NephCure is a U.S. tax exempt 501(c)(3) public charity.








